BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36948989)

  • 61. Intravenous tissue plasminogen activator for acute ischemic stroke in patients with renal dysfunction.
    Wang IK; Yen TH; Chen CH; Hsu SP; Sun Y; Lien LM; Chang WL; Lai TC; Chen PL; Chen CC; Huang PH; Lin CH; Su YC; Lin MC; Li CY; Sung FC; Hsu CY;
    QJM; 2022 Jan; 114(12):848-856. PubMed ID: 32770252
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Teoh HL; Chan BP
    Expert Rev Neurother; 2012 Feb; 12(2):209-17. PubMed ID: 22288676
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dynamic increase in neutrophil levels predicts parenchymal hemorrhage and function outcome of ischemic stroke with r-tPA thrombolysis.
    Ying A; Cheng Y; Lin Y; Yu J; Wu X; Lin Y
    Neurol Sci; 2020 Aug; 41(8):2215-2223. PubMed ID: 32180156
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
    Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator.
    Leigh R; Jen SS; Hillis AE; Krakauer JW; Barker PB;
    Stroke; 2014 Jul; 45(7):2030-5. PubMed ID: 24876245
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ischemic stroke complicating thrombolytic therapy with tenecteplase for ST elevation myocardial infarction: two case reports.
    Arous S; Haboub M; El Ghali Benouna M; Bentaoune T; Habbal R
    J Med Case Rep; 2017 Jun; 11(1):154. PubMed ID: 28601092
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke.
    Xian Y; Xu H; Lytle B; Blevins J; Peterson ED; Hernandez AF; Smith EE; Saver JL; Messé SR; Paulsen M; Suter RE; Reeves MJ; Jauch EC; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096207
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The iScore predicts clinical response to tissue plasminogen activator in Korean stroke patients.
    Park TH; Park SS; Ko Y; Lee SJ; Lee KB; Lee J; Kang K; Park JM; Choi JC; Kim DE; Cho YJ; Hong KS; Kim JT; Kim DH; Cha JK; Han MK; Lee JS; Lee J; Yu KH; Lee BC; Yoon BW; Bae HJ; Saposnik G
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):367-73. PubMed ID: 23800501
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study.
    Li S; Pan Y; Wang Z; Liang Z; Chen H; Wang D; Sui Y; Zhao X; Wang Y; Du W; Zheng H; Wang Y
    Stroke Vasc Neurol; 2022 Feb; 7(1):47-53. PubMed ID: 34429364
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treating ischaemic stroke with intravenous tPA beyond 4.5 hours under the guidance of a MRI DWI/T2WI mismatch was safe and effective.
    Bai QK; Zhao ZG; Lu LJ; Shen J; Zhang JY; Sui HJ; Xie XH; Chen J; Yang J; Chen CR
    Stroke Vasc Neurol; 2019 Mar; 4(1):8-13. PubMed ID: 31105973
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An ischemic stroke during intravenous recombinant tissue plasminogen activator infusion for evolving myocardial infarction.
    Chang GY
    Eur J Neurol; 2001 May; 8(3):267-8. PubMed ID: 11328336
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model.
    Zhang L; Zhang ZG; Zhang C; Zhang RL; Chopp M
    Stroke; 2004 Dec; 35(12):2890-5. PubMed ID: 15514182
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tenecteplase for Acute Ischemic Stroke Treatment.
    Baird AE; Jackson R; Jin W
    Semin Neurol; 2021 Feb; 41(1):28-38. PubMed ID: 33472268
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.
    Shah S; Liang L; Kosinski A; Hernandez AF; Schwamm LH; Smith EE; Fonarow GC; Bhatt DL; Feng W; Peterson ED; Xian Y
    Circ Cardiovasc Qual Outcomes; 2020 Jan; 13(1):e006031. PubMed ID: 31903770
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Atherosclerotic intracranial internal carotid artery calcification and intravenous thrombolytic therapy for acute ischemic stroke.
    Gocmen R; Arsava EM; Oguz KK; Topcuoglu MA
    Atherosclerosis; 2018 Mar; 270():89-94. PubMed ID: 29407893
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials.
    Abuelazm M; Seri AR; Awad AK; Ahmad U; Mahmoud A; Albazee E; Kambalapalli S; Abdelazeem B
    J Thromb Thrombolysis; 2023 Feb; 55(2):322-338. PubMed ID: 36449231
    [TBL] [Abstract][Full Text] [Related]  

  • 79. ST-elevation myocardial infarction after thrombolytic therapy with Tenecteplase for acute ischaemic stroke.
    Sinclair JE; Plante M; Harrison MF; Sanghavi DK
    BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37316282
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?
    Dong Y; Cao W; Cheng X; Fang K; Wu F; Yang L; Xie Y; Dong Q
    Stroke Vasc Neurol; 2016 Sep; 1(3):115-121. PubMed ID: 28959472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.